US Stock MarketDetailed Quotes

PHAR Pharming Group

Watchlist
  • 8.580
  • +0.310+3.75%
Close Apr 24 16:00 ET
586.81MMarket Cap-47.67P/E (TTM)

Pharming Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
21.15%297.2M
14.10%92.67M
12.28%74.85M
34.97%74.09M
30.66%55.59M
19.30%245.32M
48.69%81.22M
22.90%66.66M
9.47%54.9M
-8.74%42.54M
Operating revenue
21.15%297.2M
14.10%92.67M
12.28%74.85M
34.97%74.09M
30.66%55.59M
19.30%245.32M
48.69%81.22M
22.90%66.66M
9.47%54.9M
-8.74%42.54M
Cost of revenue
40.41%35.4M
71.58%12.21M
-17.79%6.82M
39.43%7.98M
105.79%8.39M
43.56%25.21M
13.45%7.12M
248.24%8.3M
42.07%5.72M
-16.44%4.08M
Gross profit
18.94%261.8M
8.58%80.46M
16.56%68.03M
34.45%66.11M
22.71%47.2M
17.04%220.1M
53.26%74.1M
12.56%58.37M
6.63%49.17M
-7.84%38.47M
Operating expense
9.52%265.47M
-0.53%66.77M
13.98%64.7M
6.60%70.15M
21.15%63.86M
36.02%242.39M
30.85%67.12M
26.88%56.76M
55.27%65.8M
32.47%52.71M
Selling and administrative expenses
13.39%99.22M
-26.77%-38.65M
22.13%43.98M
8.15%48.55M
22.24%45.34M
27.08%87.5M
-85.74%-30.48M
11.16%36.01M
60.63%44.89M
48.80%37.09M
-Selling and marketing expense
4.66%7.14M
-6.82%-84.73M
14.18%28.69M
-2.88%32.93M
11.59%30.25M
6.35%6.82M
-57.35%-79.32M
23.33%25.12M
76.12%33.91M
57.63%27.11M
-General and administrative expense
14.13%92.08M
-5.64%46.08M
40.47%15.29M
42.23%15.62M
51.16%15.09M
29.21%80.68M
43.65%48.84M
-9.47%10.89M
26.33%10.98M
29.15%9.98M
Research and development costs
20.65%83.15M
91.86%22.31M
-0.15%20.72M
3.27%21.6M
18.57%18.52M
31.19%68.91M
6.75%11.63M
68.14%20.75M
44.90%20.91M
5.09%15.62M
Depreciation amortization depletion
2.24%9.36M
----
----
----
----
27.98%9.16M
----
----
----
----
-Depreciation and amortization
2.24%9.36M
----
----
----
----
27.98%9.16M
----
----
----
----
Other operating expenses
-4.01%73.74M
----
----
----
----
54.69%76.82M
----
----
----
----
Operating profit
83.56%-3.67M
96.25%13.69M
107.67%3.33M
75.75%-4.03M
-16.96%-16.66M
-326.05%-22.29M
336.70%6.98M
-77.46%1.6M
-544.74%-16.63M
-829.61%-14.24M
Net non-operating interest income expense
-108.87%-5.09M
-1,098.53%-1.36M
-215.34%-2.17M
-512.70%-2.01M
108.35%223K
54.72%-2.44M
101.27%136K
-76.74%1.88M
110.54%488K
-244.51%-2.67M
Non-operating interest income
32.62%4.86M
-31.93%1.1M
-56.21%825K
36.09%920K
1,346.34%1.78M
4,209.41%3.66M
117.51%1.61M
-79.74%1.88M
120.94%676K
-96.19%123K
Non-operating interest expense
46.50%8.74M
-7.00%1.25M
--3M
1,034.48%1.97M
-44.33%1.56M
11.31%5.96M
-2.68%1.34M
----
-87.11%174K
102.68%2.8M
Total other finance cost
800.75%1.21M
----
----
----
----
27.62%134K
----
----
----
----
Other net income (expense)
-97.96%259K
38.13%-5.66M
296.69%356K
-69.34%5.99M
-179.17%-190K
21.01%12.71M
-106.11%-9.15M
96.95%-181K
-4.50%19.53M
-44.44%240K
Gain on sale of security
278.80%6.98M
--1.82M
--21K
----
----
-221.34%-3.9M
----
----
----
----
Earnings from equity interest
-509.00%-1.76M
-172.78%-484K
8.87%-442K
-130.00%-299K
-57.82%-535K
73.31%-289K
257.21%665K
-340.91%-485K
-19.27%-130K
23.13%-339K
Special income (charges)
-130.25%-5.03M
----
----
----
----
111.24%16.62M
----
----
----
----
-Less:Impairment of capital assets
7.81%5.03M
----
----
----
----
6.56%4.66M
----
----
----
----
-Gain on sale of business
--0
----
----
----
----
--0
----
----
----
----
-Gain on sale of property,plant,equipment
--0
----
----
----
----
--21.28M
----
----
----
----
Other non- operating income (expenses)
-75.17%71K
91.29%-1.96M
155.59%777K
-95.84%912K
-40.41%345K
-43.59%286K
-49.22%-22.53M
-53.01%304K
55.72%21.93M
-33.68%579K
Income before tax
29.30%-8.49M
428.80%6.68M
-54.22%1.51M
-101.77%-60K
0.30%-16.62M
-180.15%-12.01M
88.77%-2.03M
-64.36%3.31M
-82.69%3.39M
-493.91%-16.67M
Income tax
328.76%3.35M
249.73%3.82M
1,722.93%2.55M
-43.98%1.16M
6.49%-4.18M
-211.50%-1.46M
131.63%1.09M
-188.20%-157K
-45.82%2.07M
-678.50%-4.47M
Net income
-12.26%-11.84M
191.55%2.86M
-129.85%-1.03M
-192.34%-1.22M
-1.97%-12.45M
-177.14%-10.55M
78.65%-3.12M
-61.94%3.46M
-91.62%1.32M
-452.73%-12.21M
Net income continuous Operations
-12.26%-11.84M
191.55%2.86M
-129.85%-1.03M
-192.34%-1.22M
-1.97%-12.45M
-177.14%-10.55M
78.65%-3.12M
-61.94%3.46M
-91.62%1.32M
-452.73%-12.21M
Minority interest income
Net income attributable to the parent company
-12.26%-11.84M
191.55%2.86M
-129.85%-1.03M
-192.34%-1.22M
-1.97%-12.45M
-177.14%-10.55M
78.65%-3.12M
-61.94%3.46M
-91.62%1.32M
-452.73%-12.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-12.26%-11.84M
191.55%2.86M
-129.85%-1.03M
-192.34%-1.22M
-1.97%-12.45M
-177.14%-10.55M
78.65%-3.12M
-61.94%3.46M
-91.62%1.32M
-452.73%-12.21M
Basic earnings per share
-12.50%-0.18
180.00%0.04
-140.00%-0.02
-150.00%-0.01
0.00%-0.19
-176.19%-0.16
77.27%-0.05
-64.29%0.05
-91.67%0.02
-480.00%-0.19
Diluted earnings per share
-12.50%-0.18
180.00%0.04
-140.00%-0.02
-150.00%-0.01
0.00%-0.19
-184.21%-0.16
77.27%-0.05
-61.54%0.05
-90.91%0.02
-480.00%-0.19
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 21.15%297.2M14.10%92.67M12.28%74.85M34.97%74.09M30.66%55.59M19.30%245.32M48.69%81.22M22.90%66.66M9.47%54.9M-8.74%42.54M
Operating revenue 21.15%297.2M14.10%92.67M12.28%74.85M34.97%74.09M30.66%55.59M19.30%245.32M48.69%81.22M22.90%66.66M9.47%54.9M-8.74%42.54M
Cost of revenue 40.41%35.4M71.58%12.21M-17.79%6.82M39.43%7.98M105.79%8.39M43.56%25.21M13.45%7.12M248.24%8.3M42.07%5.72M-16.44%4.08M
Gross profit 18.94%261.8M8.58%80.46M16.56%68.03M34.45%66.11M22.71%47.2M17.04%220.1M53.26%74.1M12.56%58.37M6.63%49.17M-7.84%38.47M
Operating expense 9.52%265.47M-0.53%66.77M13.98%64.7M6.60%70.15M21.15%63.86M36.02%242.39M30.85%67.12M26.88%56.76M55.27%65.8M32.47%52.71M
Selling and administrative expenses 13.39%99.22M-26.77%-38.65M22.13%43.98M8.15%48.55M22.24%45.34M27.08%87.5M-85.74%-30.48M11.16%36.01M60.63%44.89M48.80%37.09M
-Selling and marketing expense 4.66%7.14M-6.82%-84.73M14.18%28.69M-2.88%32.93M11.59%30.25M6.35%6.82M-57.35%-79.32M23.33%25.12M76.12%33.91M57.63%27.11M
-General and administrative expense 14.13%92.08M-5.64%46.08M40.47%15.29M42.23%15.62M51.16%15.09M29.21%80.68M43.65%48.84M-9.47%10.89M26.33%10.98M29.15%9.98M
Research and development costs 20.65%83.15M91.86%22.31M-0.15%20.72M3.27%21.6M18.57%18.52M31.19%68.91M6.75%11.63M68.14%20.75M44.90%20.91M5.09%15.62M
Depreciation amortization depletion 2.24%9.36M----------------27.98%9.16M----------------
-Depreciation and amortization 2.24%9.36M----------------27.98%9.16M----------------
Other operating expenses -4.01%73.74M----------------54.69%76.82M----------------
Operating profit 83.56%-3.67M96.25%13.69M107.67%3.33M75.75%-4.03M-16.96%-16.66M-326.05%-22.29M336.70%6.98M-77.46%1.6M-544.74%-16.63M-829.61%-14.24M
Net non-operating interest income expense -108.87%-5.09M-1,098.53%-1.36M-215.34%-2.17M-512.70%-2.01M108.35%223K54.72%-2.44M101.27%136K-76.74%1.88M110.54%488K-244.51%-2.67M
Non-operating interest income 32.62%4.86M-31.93%1.1M-56.21%825K36.09%920K1,346.34%1.78M4,209.41%3.66M117.51%1.61M-79.74%1.88M120.94%676K-96.19%123K
Non-operating interest expense 46.50%8.74M-7.00%1.25M--3M1,034.48%1.97M-44.33%1.56M11.31%5.96M-2.68%1.34M-----87.11%174K102.68%2.8M
Total other finance cost 800.75%1.21M----------------27.62%134K----------------
Other net income (expense) -97.96%259K38.13%-5.66M296.69%356K-69.34%5.99M-179.17%-190K21.01%12.71M-106.11%-9.15M96.95%-181K-4.50%19.53M-44.44%240K
Gain on sale of security 278.80%6.98M--1.82M--21K---------221.34%-3.9M----------------
Earnings from equity interest -509.00%-1.76M-172.78%-484K8.87%-442K-130.00%-299K-57.82%-535K73.31%-289K257.21%665K-340.91%-485K-19.27%-130K23.13%-339K
Special income (charges) -130.25%-5.03M----------------111.24%16.62M----------------
-Less:Impairment of capital assets 7.81%5.03M----------------6.56%4.66M----------------
-Gain on sale of business --0------------------0----------------
-Gain on sale of property,plant,equipment --0------------------21.28M----------------
Other non- operating income (expenses) -75.17%71K91.29%-1.96M155.59%777K-95.84%912K-40.41%345K-43.59%286K-49.22%-22.53M-53.01%304K55.72%21.93M-33.68%579K
Income before tax 29.30%-8.49M428.80%6.68M-54.22%1.51M-101.77%-60K0.30%-16.62M-180.15%-12.01M88.77%-2.03M-64.36%3.31M-82.69%3.39M-493.91%-16.67M
Income tax 328.76%3.35M249.73%3.82M1,722.93%2.55M-43.98%1.16M6.49%-4.18M-211.50%-1.46M131.63%1.09M-188.20%-157K-45.82%2.07M-678.50%-4.47M
Net income -12.26%-11.84M191.55%2.86M-129.85%-1.03M-192.34%-1.22M-1.97%-12.45M-177.14%-10.55M78.65%-3.12M-61.94%3.46M-91.62%1.32M-452.73%-12.21M
Net income continuous Operations -12.26%-11.84M191.55%2.86M-129.85%-1.03M-192.34%-1.22M-1.97%-12.45M-177.14%-10.55M78.65%-3.12M-61.94%3.46M-91.62%1.32M-452.73%-12.21M
Minority interest income
Net income attributable to the parent company -12.26%-11.84M191.55%2.86M-129.85%-1.03M-192.34%-1.22M-1.97%-12.45M-177.14%-10.55M78.65%-3.12M-61.94%3.46M-91.62%1.32M-452.73%-12.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -12.26%-11.84M191.55%2.86M-129.85%-1.03M-192.34%-1.22M-1.97%-12.45M-177.14%-10.55M78.65%-3.12M-61.94%3.46M-91.62%1.32M-452.73%-12.21M
Basic earnings per share -12.50%-0.18180.00%0.04-140.00%-0.02-150.00%-0.010.00%-0.19-176.19%-0.1677.27%-0.05-64.29%0.05-91.67%0.02-480.00%-0.19
Diluted earnings per share -12.50%-0.18180.00%0.04-140.00%-0.02-150.00%-0.010.00%-0.19-184.21%-0.1677.27%-0.05-61.54%0.05-90.91%0.02-480.00%-0.19
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Giansun Precision Technology Group
001400
+78.53%
Heilongjiang Tianyouwei Electronics
603202
+24.06%
Joy Kie Corporation
300994
+20.03%
4
Kingchem
301509
+20.02%
5
Hunan Er-kang Pharmaceutical
300267
+20.00%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.